MOUNTAIN VIEW, Calif., Jan. 30 /PRNewswire/ -- Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, today announced that it will release its sequencing data publically for the first time at the 10th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., from Feb. 4-7.
Dr. Clifford Reid, chairman, president and CEO of Complete Genomics, will review the analysis results during his presentation titled: "Complete Genomics: Revolutionizing Human Genome Sequencing" on Thursday, Feb. 5, at 9:10 p.m. in the Islands Ballroom at the Marco Island Marriott Resort and Spa in Marco Island, Fla.
About Complete Genomics
Founded in 2006, Complete Genomics is a California company that has developed a novel approach to sequencing human DNA. Complete Genomics plans to combine its proprietary third-generation DNA sequencing technology and its high-performance computing capabilities to create a human genome sequencing service that will deliver low-cost, high-quality data on an unprecedented scale. The company is currently building the world's largest human genome sequencing center. This development will allow pharmaceutical and biotechnology customers, for the first time, to conduct large-scale human genome studies that will help identify the genetic underpinnings of complex diseases and drug responses. For additional information about the company, please visit http://www.completegenomics.com.
CONTACT: Jennifer Turcotte, Vice President, Marketing of Complete Genomics
Inc., +1-650-943-2846, jturcotte@completegenomics.com; or Lisa Osborne,
Account Director of Waggener Edstrom Worldwide Healthcare, +1-202-261-7806,
lisao@waggeneredstrom.com, for Complete Genomics Inc.
Web site: http://www.completegenomics.com/
